LifeVantage Presents TrueScience Skincare Regimen at IFSCC Conference
September 25 2015 - 09:00AM
LifeVantage Corporation (Nasdaq:LFVN), announced today that
Nathalie Chevreau, PhD, Senior Vice President of Research and
Development, presented two abstracts describing the innovative
aspects of TrueScience skin care regimen at the 2015 International
Federation of Societies of Cosmetic Chemists Conference in Zurich,
Switzerland.
Dr. Chevreau presented the anti-aging effect of the TrueScience
skin care regimen through gene modulation in the skin layers, as
well as a treatment of intrinsic and extrinsic aging. Visible
and measurable clinical outcomes can be attributed to the unique
Nrf2 ingredients extensive anti-aging efficacy and reversal of
cellular stress and DNA damage.
The International Federation of Societies of Cosmetic Chemists
(IFSCC) is a worldwide federation dedicated to international
cooperation in cosmetic science and technology. Currently 47
Societies representing 57 countries are members. Individual
membership now exceeds 15,000.
“IFSCC is the highest platform to present scientific findings in
cosmetic science,” said Dr. Chevreau. “The TrueScience skin care
regimen uniquely demonstrates the benefit of Nrf2 technology to
protect the skin from oxidative stress. This is a fantastic
invitation for LifeVantage to step onto the world stage as the
leader in anti-aging skin care and cellular stress protection.”
About LifeVantage Corporation LifeVantage
Corporation (Nasdaq:LFVN), is a science based network marketing
company dedicated to visionary science that looks to transform
health, wellness and anti-aging internally and externally at the
cellular level. The company is the maker of Protandim®, the Nrf2
Synergizer® patented dietary supplement, the TrueScience™
Anti-Aging Skin Care Regimen, Canine Health, and the AXIO™ energy
product line. LifeVantage was founded in 2003 and is
headquartered in Salt Lake City, Utah.
Forward Looking StatementsThis document
contains forward-looking statements made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. Words and expressions reflecting optimism, satisfaction or
disappointment with current prospects, as well as words such as
"believe", "hopes", "intends", "estimates", "expects", "projects",
"plans", "anticipates", "look forward to", “goal”, and variations
thereof, identify forward-looking statements, but their absence
does not mean that a statement is not forward-looking. Examples of
forward-looking statements include, but are not limited to,
statements we make regarding our leadership in the global market,
future growth and financial performance. Such forward-looking
statements are not guarantees of performance and the Company's
actual results could differ materially from those contained in such
statements. These forward-looking statements are based on the
Company's current expectations and beliefs concerning future events
affecting the Company and involve known and unknown risks and
uncertainties that may cause the Company's actual results or
outcomes to be materially different from those anticipated and
discussed herein. These risks and uncertainties include, among
others, those discussed in greater detail in the Company's Annual
Report on Form 10-K and the Company's Quarterly Report on Form 10-Q
under the caption "Risk Factors", and in other documents filed by
the Company from time to time with the Securities and Exchange
Commission. The Company cautions investors not to place undue
reliance on the forward-looking statements contained in this
document. All forward-looking statements are based on information
currently available to the Company on the date hereof, and the
Company undertakes no obligation to revise or update these
forward-looking statements to reflect events or circumstances after
the date of this document, except as required by law.
Company Relations Contact:
John Genna (801) 432-9172
Vice President of Communications &
Corporate Partnerships
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Mar 2023 to Mar 2024